Recruiting

Observational Study

Sponsor:

Jewish General Hospital

Code:

NCT06701929

Conditions

Quality Improvement

Quality of Recovery From Anaesthesia

Cesarean Section

Fasting ( 6H for Solid ; 2H for Clear Fluid )

Eligibility Criteria

Sex: Female

Age: 0+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

This study will evaluate the effect of fasting duration and elective c-section start time on the overall quality of recovery. Patients will be seen 24 hours after surgery to answer 11 questions on their overall recovery after surgery. Several factors will be tracked to determine their effect on recovery, with the primary variable of interesting

Conditions

Quality Improvement

Quality of Recovery From Anaesthesia

Cesarean Section

Fasting ( 6H for Solid ; 2H for Clear Fluid )

Study ID

NCT06701929

Start date

Mar 18, 2025

Status verified date

Aug, 2026

Completion date

Oct 31, 2026

Anticipated

Primary completion date

Aug 10, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: Female

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Presenting for elective c-section under spinal anesthesia

Exclusion Criteria:

  • Unable to communicate in French or English
  • Urgent c-section
  • Planned general anesthesia

Study Design

Enrollment

100 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Obstetric Quality of Recovery (ObsQoR-11) [ Time Frame: 3 months ]

Central Contacts and Locations

Central contacts

Matthew Cameron, MDCM MPH

514-340-8222matthew.cameron@mcgill.ca

Locations

Jewish General Hospital

Recruiting

Montreal, Quebec, Canada, H3T1E2

Contacts

Mattheq Cameron, MDCM MPH FRCPC

514-340-8222matthew.cameron.med@ssss.gouv.qc.ca

More Information

Sponsor

Jewish General Hospital

Last update posted

Aug 10, 2026

Last verified

Aug, 2026

Keywords

  • Quality of Recovery
  • cesarean section
  • fasting duration

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Jewish General Hospital on 2026-08-10.